Page 8 - Nucleus: Fall 2022 Magazine for the Penn State Ken and Mary Alice Lindquist Department of Nuclear Engineering

Q&A
Q&A
Q&A
Q&A
Why did you choose Penn State?
I chose Penn State because of its academic excellence The position provides me with the opportunity to continue my research while developing areas
that are not currently present within the Penn State system The College of Engineering has a a a a a a rich intellectual environment and broad support that will allow me to to continue to to make translational impact It is an an excellent opportunity to to to continue my research at a a a a a top-tier engineering school and also contribute to to to leadership Could you you describe your research background?
A
major focus of the Pan Laboratory is converging “molecule-making” with “device-making” in in order to solve complex biological problems My research is based on on the premise that integrated solutions to problems can be formulated by in-silico-to-in-vivo approaches and synergistic developments in in in the areas
of drug delivery molecularly specific contrast probes their applications in preclinical and and clinical clinical models and and biosensing My research team is dedicated to making nanomedicine patient-specific by using a a a a a multidisciplinary “omics” approach We study structure function and engineering processes to create materials for molecular imaging drug delivery delivery and non-viral gene delivery delivery applications We also develop immuno-nanomedicine and radiotheranostic approaches to cancer and other biomedical problems We integrate basic science and engineering with medicine to provide image-guided drug delivery for cardiovascular infectious and oncological conditions What are some goals you hope to achieve at at at Penn State?
I am am aiming to create a a a a a a a a “Penn State-flavored” program comprising biomedical nuclear medicine and materials science At the departmental level we are aiming to build a a a a a a a a nuclear medicine program at at at Penn State that emphasizes the inclusion retention and promotion of those traditionally underrepresented
in in STEM Traditionally nuclear nuclear medicine hasn’t been a a a a a a huge focus of nuclear nuclear engineering programs around the country This needs to to change and we aim to to demonstrate the the power of nuclear engineering in in in health to the the next generation of nuclear engineers I’m hoping to build collaborations between fundamental science engineering and clinical health to catalyze discovery develop new areas
of growth engage industry and foster entrepreneurial activity Dipanjan Pan Dorothy Foehr Huck Huck & J Lloyd Huck Huck Chair Professor in in Nanomedicine
Career Background
Instructor assistant professor
St Louis School of of Medicine Washington University
Associate professor
director of of of the master
of of of engineering program associate head of of the graduate program Department of Bioengineering University
of Illinois Urbana- Champaign
Director of course development Carle Illinois College of Medicine Professor of of radiology and and chemical chemical biochemical and and environmental engineering associate director and and liaison for engineering and and medicine initiative
University
of Maryland
Founder/co-founder
KaloCyte Inc Innsight Tech Inc VitruVian Bio and RNA Disease Diagnostics Inc 8 NUCLEUS